The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Candel Therapeutics Inc shares valued at $97,783 were sold by Barone Francesca on Jan 15 ’25. At $7.22 per share, Barone Francesca sold 13,534 shares. The insider’s holdings dropped to 110,673 shares worth approximately $0.77 million following the completion of this transaction.
Also, Tyagarajan Seshu sold 14,322 shares, netting a total of over 103,476 in proceeds. Following the sale of shares at $7.22 each, the insider now holds 96,790 shares.
Before that, Schoch Charles had sold 9,511 shares from its account. In a trade valued at $68,717, the insider traded Candel Therapeutics Inc shares for $7.22 each. Upon closing the transaction, the insider’s holdings decreased to 9,511 shares, worth approximately $0.3 million.
As published in their initiating research note from H.C. Wainwright on December 02, 2022, Candel Therapeutics Inc [CADL] has been a Buy and the price target has been revised to $11. Analysts at BMO Capital Markets started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of August 23, 2021, UBS has initiated its “Buy” rating for CADL. Earlier on August 23, 2021, Jefferies initiated its rating. Their recommendation was “a Buy” for CADL stock.
Analyzing CADL Stock Performance
During the last five days, there has been a drop of approximately -1.42%. Over the course of the year, Candel Therapeutics Inc shares have dropped approximately -19.82%. Shares of the company reached a 52-week high of $9.40 on 01/06/25 and a 52-week low of $6.31 on 01/28/25. A 50-day SMA is recorded $6.72, while a 200-day SMA reached $6.72. Nevertheless, trading volume fell to 0.65 million shares from 0.9 million shares the previous day.
Support And Resistance Levels for Candel Therapeutics Inc (CADL)
According to the 24-hour chart, there is a support level at 6.77, which, if violated, would cause prices to drop to 6.58. In the upper region, resistance lies at 7.13. The next price resistance is at 7.30. RSI (Relative Strength Index) is 47.33 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.40, which suggests the price will decrease in the coming days. Percent R is at 72.68%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
